These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2013120)

  • 1. Phase II study of teniposide in adenocarcinoma of the lung.
    Sørensen JB; Bach F; Dombernowsky P; Hansen HH
    Cancer Chemother Pharmacol; 1991; 27(6):487-9. PubMed ID: 2013120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase I study of oral teniposide (VM-26).
    Smit EF; Ousterhuis BE; Berendsen HH; Sleijfer DT; Postmus PE
    Semin Oncol; 1992 Apr; 19(2 Suppl 6):35-9. PubMed ID: 1329226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase II study of teniposide in advanced breast cancer.
    Boas J; Rasmussen D; Hansen OP; Engelholm SA; Dombernowsky P
    Cancer Chemother Pharmacol; 1990; 25(6):463-4. PubMed ID: 2311176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A phase I study of daily oral teniposide for 20 days.
    Smit EF; Splinter TA; Kok TC
    Semin Oncol; 1992 Apr; 19(2 Suppl 6):40-2. PubMed ID: 1411637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of extensive small cell lung cancer with carboplatin and teniposide.
    Sørensen BT; Nielsen K; Steenholdt S; Schultz H; Jakobsen A
    Eur J Cancer; 1991; 27(9):1109-12. PubMed ID: 1659851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of brain metastases of small cell lung cancer with teniposide.
    Postmus PE; Smit EF; Berendsen HH; Sleijfer DT; Haaxma-Reiche H
    Semin Oncol; 1992 Apr; 19(2 Suppl 6):89-94. PubMed ID: 1329230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Teniposide in the treatment of non-small cell lung carcinoma.
    Giaccone G; Donadio M; Ferrati P; Bonardi G; Ciuffreda L; Bagatella M; Calciati A
    Cancer Treat Rep; 1987 Jan; 71(1):83-5. PubMed ID: 3024829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinical impact of teniposide in the treatment of elderly patients with small-cell lung cancer.
    Cascinu S; Del Ferro E; Ligi M; Graziano F; Catalano G
    Am J Clin Oncol; 1997 Oct; 20(5):477-8. PubMed ID: 9345331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. VM26 (NSC-122819): a clinical study in advanced cancer of the lung and ovary.
    Samson MK; Baker LH; Talley RW; Fraile RJ
    Eur J Cancer (1965); 1978 Dec; 14(12):1395-9. PubMed ID: 216556
    [No Abstract]   [Full Text] [Related]  

  • 10. The European Organization for Research and Treatment of Cancer experience with teniposide: preliminary results of a randomized study in non-small cell lung cancer.
    Giaccone G; Splinter TA; Kirkpatrick A; Dalesio O; van Zandwijk N; McVie JG
    Semin Oncol; 1992 Apr; 19(2 Suppl 6):98-102. PubMed ID: 1329231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Teniposide for brain metastases of small-cell lung cancer: a phase II study. European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group.
    Postmus PE; Smit EF; Haaxma-Reiche H; van Zandwijk N; Ardizzoni A; Quoix E; Kirkpatrick A; Sahmoud T; Giaccone G
    J Clin Oncol; 1995 Mar; 13(3):660-5. PubMed ID: 7884426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Teniposide (VM-26) in patients with advanced endometrial carcinoma. A phase II trial of the Gynecologic Oncology Group.
    Muss HB; Bundy BN; Adcock L
    Am J Clin Oncol; 1991 Feb; 14(1):36-7. PubMed ID: 1987736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase II study of teniposide in patients with AIDS-related Kaposi's sarcoma.
    Schwartsmann G; Sprinz E; Kronfeld M; Vinholes J; Sander E; Zampese M; Preger R; Kalakun L; Brunetto AL
    Eur J Cancer; 1991; 27(12):1637-9. PubMed ID: 1782075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase II study of teniposide in small cell carcinoma of the lung.
    Pedersen AG; Bork E; Osterlind K; Dombernowsky P; Hansen HH
    Cancer Treat Rep; 1984 Oct; 68(10):1289-91. PubMed ID: 6098366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Teniposide (VM-26), an overlooked highly active agent in small-cell lung cancer. Results of a phase II trial in untreated patients.
    Bork E; Hansen M; Dombernowsky P; Hansen SW; Pedersen AG; Hansen HH
    J Clin Oncol; 1986 Apr; 4(4):524-7. PubMed ID: 3007684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effective reinduction therapy for childhood acute nonlymphoid leukemia using simultaneous continuous infusions of teniposide and amsacrine.
    Mirro J; Kalwinsky DK; Grier HE; Santana VM; Mason C; Murphy SB; Dahl GV
    Cancer Chemother Pharmacol; 1989; 24(2):123-7. PubMed ID: 2731312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase II study of VM-26 in adult malignancies.
    Spremulli E; Schulz JJ; Speckhart VJ; Wampler GL
    Cancer Treat Rep; 1980 Jan; 64(1):147-9. PubMed ID: 7379049
    [No Abstract]   [Full Text] [Related]  

  • 18. High-dose teniposide for refractory malignancies: a phase I study.
    de Vries EG; Mulder NH; Postmus PE; Vriesendorp R; Willemse PH; Sleijfer DT
    Cancer Treat Rep; 1986 May; 70(5):595-8. PubMed ID: 3708608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Teniposide (VM26): an effective treatment for brain metastases of small cell carcinoma of the lung.
    Giaccone G; Donadio M; Bonardi GM; Testore F; Calciati A
    Eur J Cancer Clin Oncol; 1988 Apr; 24(4):629-31. PubMed ID: 2838291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Teniposide in advanced breast cancer. A phase II trial in patients with no prior chemotherapy.
    Nielsen D; Boas J; Engelholm SA; Hansen OP; Dombernowsky P
    Ann Oncol; 1992 May; 3(5):377-8. PubMed ID: 1616891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.